Nivolumab
CA209-649
Phase 3 small_molecule completed
Quick answer
Nivolumab for Gastric Cancer is a Phase 3 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Gastric Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed